View More View Less
  • 1 Professor at Stanford University and National Bureau of Economic Research, Director of the Asia Health Policy Program
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $700.00

The economic challenges countries face when adopting personalized medicine technologies provide an important illustration of many of the concepts articulated by János Kornai in his pioneering research on innovation in market-driven, capitalist surplus economies. In Chinese philosophy, Yin and Yang often represent contradictory yet inseparable opposites – two forces that not merely coexist, but are synergistic and mutually dependent. This concept is an apt analogy for the relationship between innovation and shortage in the health sector. Dangers arise from over-emphasizing the Yin of innovation over the Yang of access, and vice versa. If we over-constrain innovation, we die needlessly early and forfeit quality of life that innovations might have enabled. If we do not distribute access to innovations equitably, we diminish our humanity, suffer backlashes from populism and distrust of science and expertise, and risk social instability, even violent conflict.

  • Arrow, K. J. (1963): Uncertainty and the Welfare Economics of Medical Care. American Economic Review, 53(5): 941973.

  • Babiarz, K. S.Eggleston, K.Miller, G.Zhang, Q. (2015): An Exploration of China’s Mortality Decline under Mao: A Provincial Analysis, 1950–80. Population Studies, 69(1): 3956.

    • Search Google Scholar
    • Export Citation
  • Berndt, E. R.Trusheim, M. R. (2017): The Information Pharms Race and Competitive Dynamics of Precision Medicine. Paper Presented at the National Bureau of Economic Research Conference on Economic Dimensions of Personalized and Precision Medicine, Santa Monica, CA, September, 2017.

    • Search Google Scholar
    • Export Citation
  • Čatić, T. (2016): Market Access Pricing in Central and Eastern Europe: Practical Guide to Successful Reimbursement in Bosnia and Herzegovina. ISPOR Central & Eastern Europe Network Newsletter 4(1). Https://Www.Ispor.Org/Ceenetwork/Newsletter/2016/Guide-To-Successful-Reimbursement-Bosnia-Herzegovina-And-Ukraine.Pdf.

    • Search Google Scholar
    • Export Citation
  • Cybulski, J. S.Clements, J.Prakash, M. (2014): Foldscope: Origami-Based Paper Microscope. Plos One 9(6): E98781.

  • Chernew, M. E.Newhouse, J. P. (2012): Health Care Spending Growth. Handbook of Health Economics, 2: 143.

  • Deaton, A. (2003): Health, Inequality, and Economic Development. Journal of Economic Literature, 41(1): 113158.

  • Deaton, A. (2013): The Great Escape: Health, Wealth, and the Origins of Inequality. Princeton University Press.

  • Eggleston, K. (2016): Innovation, Shortage, and the Economics of Health Care Systems. In: Hámori, B.Rosta, M. (eds): Constraints and Driving Forces in Economic Systems: Studies in Honour of János Kornai. Cambridge Scholars Publishing, pp. 1529.

    • Search Google Scholar
    • Export Citation
  • European Medicines Agency (2017): Herceptin. EMA.Europa.Eu. (Last Updated April 19, 2017, accessed September 5, 2017. http://Www.Ema.Europa.Eu/Ema/Index.Jsp?Curl=Pages/Medicines/Human/Medicines/000278/Human_Med_000818.Jsp&Murl=Menus/Medicines/Medicines.Jsp&Mid=WC0b01ac058001d125).

  • Frye, J. E. (ed.) (2015): International Drug Price Indicator Guide. MSH.Org. July 2, 2015. (Accessed September 5, 2017. http://Apps.Who.Int/Medicinedocs/Documents/S21982en/S21982en.Pdf.)

    • Search Google Scholar
    • Export Citation
  • Gulácsi, L.Orlewska, E.Péntek, M. (2012): Health Economics and Health Technology Assessment in Central and Eastern Europe: A Dose of Reality. The European Journal of Health Economics, 13(5): 525531. https://Link.Springer.Com/Article/10.1007%2Fs10198-012-0411-X.

    • Search Google Scholar
    • Export Citation
  • Hamburg, M.Collins, F. (2010): The Path to Personalized Medicine. The New England Journal of Medicine, 363(4): 301304.

  • Kornai, J.Eggleston, K. (2001): Welfare, Choice and Solidarity in Transition: Reforming the Health Sector in Eastern Europe. Cambridge, UK: Cambridge University Press.

    • Search Google Scholar
    • Export Citation
  • Kornai, J. (2013): Dynamism, Rivalry, and the Surplus Economy: Two Essays on the Nature of Capitalism. Oxford University Press.

  • Management Sciences for Health (2014): Trastuzumab. Mshpriceguide.Org., January, 2014. (Accessed September 5, 2017. http://Mshpriceguide.Org/En/Single-Drug-Information/?Dmfid=147 1&Searchyear=2014).

    • Search Google Scholar
    • Export Citation
  • Mayor, S. (2016): Differences in Availability of Cancer Drugs across Europe. The Lancet Oncology, 17(9): 1196. http://Www.Thelancet.Com/Journals/Lanonc/Article/PIIS1470-2045(16)30378-3/Fulltext.

    • Search Google Scholar
    • Export Citation
  • NCK Pharma Solution (2017): Mylan Settles Trastuzumab Patent Litigation with Genentech and Roche. Nckpharma.Com., March 15, 2017. (Accessed September 5, 2017. https://Nckpharma.Com/Index.Php/Mylan-Settles-Trastuzumab-Patent-Litigation-With-Genentech-And-Roche/).

    • Search Google Scholar
    • Export Citation
  • Neumann, P. J.Ganiats, Th. G.Russell, L. B.Sanders, G. D.Siegel, J. E. (2017) (eds): Cost Effectiveness in Health and Medicine. Oxford University Press.

    • Search Google Scholar
    • Export Citation
  • Nobelprize.Org. (2017): Youyou Tu –Facts. Nobel Media AB 2014. (Accessed: 12 Oct 2017, <http://Www.Nobelprize.Org/Nobel_Prizes/Medicine/Laureates/2015/Tu-Facts.Html>

    • Search Google Scholar
    • Export Citation
  • Ross-Degnan, D. – Lu, Ch. Y. – Chaiyakunapruk, N.Wagner, A. K. (2015): Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand. PLOS ONE (2015). http://Journals.Plos.Org/Plosone/Article?Id=10.1371/Journal.Pone.0119945.

    • Search Google Scholar
    • Export Citation
  • Singhroy, D.Love, J. (2016): Proposal for the Inclusion of Trastuzumab Emtansine (T-Dm1) in the WHO Model List of Essential Medicines for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer. Knowledge Ecology International, December, 2016. (Accessed September 5, 2017. http://Www.Who.Int/Selection_Medicines/Committees/Expert/21/ Applications/S8_Trastuzumab_Emtansine.Pdf?Ua=1).

    • Search Google Scholar
    • Export Citation
  • Wait, S. (2016): Access to Immuno-Oncology Therapies – European Policy Perspective. The American Journal of Managed Care, 20(2). http://Www.Ajmc.Com/Journals/Evidence-Based-Oncology/2016/February-2016/Access-To-Immuno-Oncology-Therapies-European-Policy-Perspective/P-1.

    • Search Google Scholar
    • Export Citation
  • World Health Organization (2015): 19th WHO Model List of Essential Medicines. WHO.Int., April, 2015. (Accessed September 5, 2017. http://Www.Who.Int/Medicines/Publications/Essentialmedicines/ EML_2015_FINAL_Amended_NOV2015.Pdf?Ua=1).

    • Search Google Scholar
    • Export Citation
  • Xu, Ch. (2017): Capitalism and Socialism: A Review of Kornai’s Dynamism, Rivalry, and the Surplus Economy. Journal of Economic Literature, 55(1): 191208.

    • Search Google Scholar
    • Export Citation
Submit Your Manuscript
 
The author instruction is available in PDF.
Please, download the file from HERE.

 

The description of the refereeing procedure is available in PDF.
Please, download the file from HERE.

 

 

Senior editors

Editor(s)-in-Chief: Prof. Dr. Mihályi, Péter

Editor(s): Ványai, Judit

Editorial Board

  • Ádám Török (Chairman) / University of Pannonia; Budapest University of Technology and Economics
  • Edina Berlinger / Corvinus University of Budapest, Department of Finance
  • Péter Halmai / Budapest University of Technology and Economics; National University of Public Service
  • Gábor Kézdi / University of Michigan
  • István Kónya / Institute of Economics Centre for Regional and Economic Studies, University of Pécs
  • János Köllő / Institute of Economics Centre for Regional and Economic Studies
  • István Magas / Corvinus University of Budapest, Department of World Economy; University of Physical Education, Department. of Sports and Decision Sciences
 

Advisory Board

  • Ǻslund, Anders
  • Kolodko, Grzegorz
  • Mau, Vladimir
  • Messerlin, Patrick A
  • Nuti, Mario Domenico
  • Wagener, Hans-Jürgen

Corvinus University of Budapest
Department of Economics
Fővám tér 8 Budapest, H-1093, Hungary

Indexing and Abstracting Services:

  • EconLit
  • Elsevier GEO Abstracts
  • GEOBASE
  • International Bibliographies IBZ and IBR
  • JEL
  • Referativnyi Zhurnal
  • RePEc
  • SCOPUS
  • Social Science Citation Index
  • Index Copernicus

 

2020  
Total Cites 275
WoS
Journal
Impact Factor
0,875
Rank by Economics 325/377 (Q4)
Impact Factor  
Impact Factor 0,534
without
Journal Self Cites
5 Year 0,500
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Economics 347/549 (Q3)
Citation Indicator   
Citable 37
Items
Total 37
Articles
Total 0
Reviews
Scimago 13
H-index
Scimago 0,292
Journal Rank
Scimago Economics and Econometrics Q3
Quartile Score  
Scopus 225/166=1,4
Scite Score  
Scopus Economics and Econometrics 392/661 (Q3)
Scite Score Rank  
Scopus 0,668
SNIP  
Days from  289
sumbission  
to acceptance  
Days from  447
acceptance  
to publication  

2019  
Total Cites
WoS
212
Impact Factor 0,914
Impact Factor
without
Journal Self Cites
0,728
5 Year
Impact Factor
0,650
Immediacy
Index
0,156
Citable
Items
45
Total
Articles
45
Total
Reviews
0
Cited
Half-Life
3,9
Citing
Half-Life
9,5
Eigenfactor
Score
0,00015
Article Influence
Score
0,052
% Articles
in
Citable Items
100,00
Normalized
Eigenfactor
0,01891
Average
IF
Percentile
28,437
Scimago
H-index
12
Scimago
Journal Rank
0,439
Scopus
Scite Score
214/165=1,3
Scopus
Scite Score Rank
Economics and Econometrics 355/637 (Q3)
Scopus
SNIP
0,989

 

Acta Oeconomica
Publication Model Hybrid
Submission Fee none
Article Processing Charge 900 EUR/article
Printed Color Illustrations 40 EUR (or 10 000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 588 EUR / 732 USD
Print + online subscription: 688 EUR / 860 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Oeconomica
Language English
Size B5
Year of
Foundation
1966
Publication
Programme
2021 Volume 71
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0001-6373 (Print)
ISSN 1588-2659 (Online)